Effect of polymyxin B-immobilized fiber on blood metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in acute respiratory distress syndrome patients

Blood Purification

Volumn 22, Issue 3, 2004, Pages 256-260

  Nakamura, Tsukasa ^a   Kawagoe, Yasuhiro ^a   Matsuda, Takaharu ^a   Shoji, Hisataka ^b   Ueda, Yoshihiko ^c   Tamura, Naoaki ^d   Ebiharad, Isao ^d   Koide, Hikaru ^d  

^a Shinmatsudo Central General Hospital   (Japan)

^b Toray Medical Company   (Japan)

^c DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KOTO HOSPITAL   (Japan)

Author keywords

Extracellular matrix; Metalloproteinase 9; Polymyxin B immobilized fiber; Tissue inhibitor of metalloproteinase 1

Indexed keywords

ANTIBIOTIC AGENT; GELATINASE B; POLYMYXIN B; POLYMYXIN B IMMOBILIZED FIBER; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; MALE; MORTALITY; OXYGEN TENSION; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; THORAX RADIOGRAPHY;

AGED; BLOOD PRESSURE; ENDOTOXINS; FEMALE; HEMOPERFUSION; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POLYMYXIN B; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY FUNCTION TESTS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TREATMENT OUTCOME;

EID: 4444255141     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078494     Document Type: Article

References (31)

1. Moraes TJ, Chow CW, Downey GP: Proteases and lung injury. Crit Care Med 2003;31(suppl 4):S189-S194.
2. Udobi KF, Childs E, Touijer K: Acute respiratory distress syndrome. Am Fam Physician 2003;67:315-322.
3. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-1349.
4. Lanchou J, Corbel M, Tanguy M, Germain N, Boichot E, Theret N, Clement B, Lagente V, Malledant Y: Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients. Crit Care Med 2003;31:536-642.
5. Nakamura T, Ushiyama C, Suzuki S, Ebihara I, Shimada N, Koide H: Elevation of serum levels of metalloproteinase-1, tissue inhibitor of metalloproteinase-1 and type IV collagen, and plasma levels of metalloproteinase-9 in polycystic kidney disease. Am J Nephrol 2000;20:32-36.
6. Ebihara I, Nakamura T, Shimada N, Koide H: Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus. Am J Kidney Dis 1998;32:544-550.
7. Nakamura T, Ebihara I, Shimada N, Shoji H, Koide H: Modulation of plasma metalloproteinase-9 concentrations and peripheral blood monocyte mRNA levels in patients with septic shock: Effect of fiber-immobilized polymyxin B treatment. Am J Med Sci 1998;316:355-360.
8. Lorenzl S, Albers DS, Relkin N, Ngyuen T, Hilgenberg SL, Chirchigno J, Cudkowicz ME, Beal MF: Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease. Neurochem Int 2003;43:191-196.
9. Nakamura T, Ushiyama C, Suzuki S, Shimada N, Ebihara I, Suzaki M, Takahashi T, Koide H: Effect of plasma exchange on serum tissue inhibitor of metalloproteinase 1 and cytokine concentrations in patients with fulminant hepatitis. Blood Purif 2000;18:50-54.
10. Nakamura T, Ushiyama C, Shimada N, Hayashi K, Ebihara I, Suzaki M, Koide H: Changes in concentrations of type IV collagen and tissue inhibitor of metalloproteinase-1 in patients with paraquat poisoning. J Appl Toxicol 2001;21:445-447.
11. Nakamura T, Ushiyama C, Shoji H, Koide H: Effects of hemoperfusion on serum cardiac troponin T concentrations using polymyxin Bimmobilized fibers in septic patients undergoing hemodialysis. ASAIO J 2002;48:41-44.
12. Nakamura T, Ushiyama C, Suzuki Y, Shoji H, Osada S, Shimada N, Koide H: Effect of polymyxin B-immobilized fibre on various mediators in patients with hypothermic sepsis. Clin Intens Care 2002;12:223-228.
13. Nakamura T, Ushiyama C, Suzuki Y, Inoue T, Shoji H, Shimada N, Koide H: Combination therapy with polymyxin B-immobilized fibre haemoperfusion and teicoplanin for sepsis due to methicillin-resistant staphylococcus aureus. J Hosp Infect 2003;53:58-63.
14. Pittet JF, Mackersie RC, Martin TR, Matthay MA: Biological markers of acute lung injury: Prognostic and pathogenic significance. Am J Respir Crit Care Med 1997;155:1187-1190.
15. Tsushima K, Kubo K, Koizumi T, Yamamoto H, Fujimoto K, Hora K, Kan-nou Y: Direct hemoperfusion using a polymyxin B immobilized column improves acute respiratory distress syndrome. J Clin Apheresis 2002;17:97-102.
16. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R: The American-European Consensus Conference on ARDS: Definition, mechanisms, relevant outcomes and clinical trial coordination. Am J Respir Crit Care Med 1994;149:811-824.
17. Aoki H, Kodama M, Tani T, Hanasawa K: Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B immobilized fiber. Am J Surg 1994;167:412-417.
18. Shoji H, Tani T, Hanasawa K, Kodama M: Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: Designing and antiendotoxin efficacy in the clinical application. Ther Apher 1998;2:3-12.
19. Fujimoto N, Hosokawa N, Iwata K, Shinya T, Okada Y, Hayakawa T: A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase gelatinase B) using monoclonal antibodies. Clin Chim Acta 1994;231:79-88.
20. Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T: Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases: An application for rheumatoid arthritis serum and plasma. J Immunol Methods 1990;127:103-108.
21. Muzzillo DA, Imoto M, Fukuda Y, Koyama Y, Saga S, Nagai Y, Hayakawa T: Clinical evaluation of serum tissue inhibitor of metalloproteinase-1 levels in patients with liver diseases. J Gastroenterol Hepatol 1993;8:437-441.
22. Akiyama K, Shikata K, Sugimoto H, Matsuda M, Shikata Y, Fujimoto N, Obata K, Matsui H, Makino H: Changes in serum concentrations of matrix metalloproteinases, tissue inhibitors of metalloproteinase and type IV collagen in patients with various types of glomerulonephritis. Res Commun Mol Pathol Pharmacol 1997;95:115-128.
23. Meduri GU, Tolley EA, Chinn A: Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Am J Respir Crit Care Med 1998;158:1432-1441.
24. Moore FD Jr, Davis CF: Monocyte activation after burns and endotoxemia. J Res Surg 1989;46:350-354.
25. Sibile Y, Reynolds HY: Macrophages and poly-morphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 1990;141:471-475.
26. Steinberg KP, Milberg JA, Martin TR, Maunder RJ, Cockrill BA, Hudson LD: Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am J Respir Crit Care Med 1994;150:113-116.
27. Hembry RM, Bagga MR, Reynolds JJ, Hamblen DL: Immunolocalization studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. Ann Rheum Dis 1995;54:25-32.
28. Yoshimura Y, Obata K, Fujimoto N, Ymashita K, Hayakawa T, Shimmei M: Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinase-1 in sera from patients with rheumatoid arthritis. Arthritis Rheum 1995;38:969-975.
29. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI: SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 1989;264:17213-17222.
30. Wahl SM, Allen JB, Weeks BS, Wong HL, Klotman PE: Transforming growth factor-beta enhances integrin expression and type IV collagenase secretion in human monocytes. Proc Natl Acd Sci USA 1993;90:4577-4581.
31. Tani T, Hanasawa K, Kodama M, Imaizumi H, Yonekawa M, Saito M, Ikeda T, Yagi Y, Takayama K, Amamo I, Shimaoka H, Ohta M, Okahisa T, Koga N, Fujita N, Yamasa H: Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patients. World J Surg 2001;25:660-668.